Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.32
05.02.24
-
05.02.25
-43.81%
08.02.24

Good culture
Risky Investment
No uniques
SynBiotic SE

Start price
Target price
Perf. (%)
€8.32
05.02.24
-
05.02.25
6.49%
17.02.24

buy
Green Hydrogen Systems A/S

Start price
Target price
Perf. (%)
€0.64
05.02.24
€1.00
05.02.25
13.04%
19.02.24

Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.40
04.02.24
€20.00
30.11.25
-77.89%
13.05.24

Could be very worthwhile Investment >20% year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
buy
2CRSI S.A.

Start price
Target price
Perf. (%)
€3.90
03.02.24
-
03.02.25
31.79%
17.02.24

Could be worthwhile Investment >10% per year
buy
Hyundai Motor Co ADR

Start price
Target price
Perf. (%)
€45.50
03.02.24
-
03.02.25
10.77%
15.02.24

Mind Medicine MindMed Inc.

Start price
Target price
Perf. (%)
€3.74
03.02.24
-
03.02.25
136.09%
01.04.24

Revenue growth >5% per year expected
Medium risks for its business
Future proof or reliable business model
Probably not worthwhile Investment
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.75
02.02.24
-
02.02.25
83.26%
21.06.24

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.48
31.01.24
-
29.02.24
230.87%
01.03.24

buy
PVA TePla AG

Start price
Target price
Perf. (%)
€21.86
30.01.24
-
30.01.25
2.01%
15.02.24

buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.65
30.01.24
-
30.01.25
-1.41%
31.01.24

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€3.75
29.01.24
-
29.01.25
-2.03%
03.02.24

Could be very worthwhile Investment >20% year
buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€0.99
29.01.24
€1.00
29.01.25
-49.90%
03.02.24

Good culture
Capable Management
Could be worthwhile Investment >10% per year
Few uniques
buy
RumbleON Inc.

Start price
Target price
Perf. (%)
€6.70
26.01.24
-
26.02.24
1.49%
27.02.24

Small challenges to pay loans and raise capital
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€10.58
25.01.24
€9.80
31.07.25
27.03%
17.02.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€76.00
25.01.24
€110.00
31.03.26
-0.66%
02.02.24

Could be very worthwhile Investment >20% year
buy
Kura Oncology Inc

Start price
Target price
Perf. (%)
€17.70
25.01.24
€16.00
31.08.25
9.60%
02.02.24

Could be very worthwhile Investment >20% year
buy
H&R GmbH & Co. KGaA

Start price
Target price
Perf. (%)
€4.80
23.01.24
€6.00
23.01.25
4.58%
03.02.24

Good culture
Revenue growth >5% per year expected
Capable Management
Little innovation
buy
Wasgau Produktions & Handels AG

Start price
Target price
Perf. (%)
€10.90
23.01.24
-
23.01.25
-6.42%
03.02.24

Top 10 in its market
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.21
23.01.24
-
23.01.25
-15.48%
03.02.24

Probably not worthwhile Investment
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€3.38
22.01.24
-
22.01.25
14.50%
03.02.24

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.92
22.01.24
-
22.01.25
-36.03%
03.02.24

Probably not worthwhile Investment
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.54
21.01.24
-
21.01.25
6.61%
03.02.24

Could be worthwhile Investment >10% per year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.67
21.01.24
-
21.01.25
18.80%
03.02.24

Could be worthwhile Investment >10% per year